BI
Biora Therapeutics, Inc.
BIOR · OTC
$0.22 +0.00% (+$0.00)
Market Cap $995.0K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
0 /100
Expensive P/S 248.75x
PEG N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 96.22%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 3,102,880.00%
Op. margin 1,678,580.00%
FCF margin 1,215,050.00%
Quality
57 /100
Average ROA 397.61%
Asset turnover 0.00x
ROIC 232.28%
Debt
50 /100
Moderate Int. coverage -11.68x
Net debt/EBITDA -0.28x
Current ratio 0.30x
Stability
37 /100
Moderate Rev. volatility 13.26%
EPS volatility 690.74%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na BIOR
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Aditya Mohanty
Employees
58
Headquarters
San Diego